TCR and HLA analysis of patients in a Phase I/Iia trial of a therapeutic CMV vaccine against recurrent glioblastoma (rGBM) September 17, 2020 | TCR and HLA analysis of patients in a Phase I/Iia trial of a therapeutic CMV vaccine against recurrent glioblastoma (rGBM) Conference: The European Society for Medical Oncology (ESMO) Virtual Congress 2020 Date: September 17, 2020